Andre Goy, MD, John Theurer Cancer Center

Articles

The Invisible Revolution

November 11th 2014

How CTCs and Circulating Naked Tumor DNA-as Liquid Biopsies-Will Transform Diagnostic and Management of Oncology Patients

Shifting the Paradigm?: Where Is Chemotherapy-and Particularly, High-Dose Therapy-Going in the Era of Biologic Agents?

October 15th 2014

The changes seen in multiple myeloma are a perfect illustration of a potentially shifting paradigm in cancer care.

Genetic Cancer Screening for All?: The Evolving BRCA1/BRCA2 Story

September 18th 2014

Numerous epidemiological factors affect the likelihood of developing breast and ovarian cancer, but no other predictor is as powerful as an inherited mutation in BRCA1 or BRCA2, genes involved in both tumor suppression and DNA repair.

A Revolution in Classifying Cancer?

August 18th 2014

A disruptive study challenges our current system in classifying cancer. Will a new molecular taxonomy of tumors arise and change our views on patient management?

ASCO 2014: Gearing Up for More Changes

July 21st 2014

The ASCO annual meeting is always a time of excitement for the nearly 30,000 clinicians and scientists who gather every year to see "what's new."

MRD: The Next Frontier in Oncology

June 19th 2014

The measurement of response to anticancer therapy has evolved over the years as a result of better therapies and progress in imaging.

NCCN Guidelines Are Effective, but Must Address Cost and Prognostic Stratification

May 27th 2014

The National Comprehensive Cancer Network (NCCN) guidelines have been a very valuable resource for practicing oncologists for 15 years.

Dr. Goy on NCCN Guidelines for Lymphomas

May 2nd 2014

Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses NCCN guidelines for the treatment of lymphomas.

Emerging Breakthroughs in Cancer Care: Toward a Revolution?

April 21st 2014

Medicine is undergoing a revolution that will transform the practice of healthcare, including oncology.

Dr. Goy on Future Agents Against Lymphoma

March 26th 2014

Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses emerging agents in lymphoma.

Precision Medicine-An Inevitable (Though Challenging) Goal!

March 26th 2014

There is no question that the era of precision medicine has arrived, and we need to embrace it and resolve together the challenges that come with it, including at the regulatory level.

Dr. Goy on the Challenges of Treating Hodgkin's Lymphoma

February 27th 2014

Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses the challenges of treating patients with Hodgkin's lymphoma.

Dr. Goy on CAR-Modified T Cells in Lymphoma

December 13th 2013

Andre Goy, MD, MS, from the John Theurer Cancer Center, discusses the apparent effectiveness of CD19-targeted CAR-modified T cells as a treatment for patients with various types of lymphoma.

Dr. Goy on Developments in the Field of Immunology

August 14th 2013

Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, comments on the recent developments in fighting cancer with the immune system.

Dr. Goy on Lenalidomide for Mantle Cell Lymphoma

June 10th 2013

Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, discusses the approval of the immunomodulatory agent lenalidomide (Revlimid).

Dr. Goy Highlights Research From the 2012 ASCO Meeting

May 30th 2012

Dr. Andre Goy, from John Theurer Cancer Center, Highlights Research From the 2012 ASCO Meeting.

Dr. Goy on Neoadjuvant Hormonal Therapy Plus Zytiga

May 18th 2012

Dr. Andrew Goy, from John Theurer Cancer Center, on Neoadjuvant Hormonal Therapy Plus Zytiga

Dr. Goy on Crizotinib for Pediatric Patients With ALCL

May 16th 2012

Dr. Andre Goy, from John Theurer Cancer Center, on Crizotinib for Pediatric Patients With ALCL

Dr. Goy Explains the Concept of Personalized Medicine

November 4th 2011

Dr. Andre Goy from John Theurer Cancer Center Explains the Concept of Personalized Medicine

Dr. Goy Highlights Recent Advances in Oncology

October 14th 2011

Dr. Andre Goy from John Theurer Cancer Center Highlights Recent Advances in Oncology